Here is the link to a fascinating and very readable New York...

Here is the link to a fascinating and very readable New York Times feature published 16 March 2018 explaining the problems associated with benzodiazepine use. Gives the reader a good feel  for the huge potential for an alternative -- BNC210 -- that is free of at least some of the extremely harmful side effects. As we know. BNC 210 has already achieved impressive phase 2 results for those indications for which bezodiazepines are most often prescribed.

https://www.nytimes.com/2018/03/16/...lights&contentPlacement=1&pgtype=sectionfront